INTERLOGRX Trademark

Trademark Overview


On Monday, February 14, 2022, a trademark application was filed for INTERLOGRX with the United States Patent and Trademark Office. The USPTO has given the INTERLOGRX trademark a serial number of 97266391. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Astellas Pharma Inc.. The INTERLOGRX trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Downloadable computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, personal digital assistants (PDAs) and mobile phones, namely, downloadable software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease, the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers
interlogrx

General Information


Serial Number97266391
Word MarkINTERLOGRX
Filing DateMonday, February 14, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements


Goods and ServicesDownloadable computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, personal digital assistants (PDAs) and mobile phones, namely, downloadable software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease, the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events


Event DateEvent Description
Friday, December 2, 2022NON-FINAL ACTION WRITTEN
Thursday, February 17, 2022NEW APPLICATION ENTERED
Friday, February 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 29, 2022ASSIGNED TO EXAMINER
Friday, December 2, 2022NON-FINAL ACTION E-MAILED
Friday, December 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024SOU EXTENSION 2 FILED
Tuesday, July 9, 2024SOU EXTENSION 2 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED